Cardiff Oncology shares plunge after Q2 earnings miss
Karen Seaberg, a director and significant shareholder of MGP Ingredients Inc. (NASDAQ:MGPI), recently sold a notable portion of her holdings in the company. According to the latest filing with the Securities and Exchange Commission, Seaberg sold a total of 12,201 shares of MGP Ingredients common stock on May 1, 2025. The stock was sold at prices ranging from $30.65 to $31.25 per share, amounting to a total transaction value of approximately $374,915. The transaction occurred as MGPI’s stock trades at $32.02, significantly below its 52-week high of $92.52, with InvestingPro analysis indicating the stock is currently undervalued.
These sales were executed under a prearranged Rule 10b5-1 trading plan, which Seaberg adopted on March 12, 2024. Following these transactions, Seaberg’s indirect holdings, through Cray MGP Holdings LP, decreased to 1,748,733 shares. The sales reflect a strategic move by Seaberg to manage her investment portfolio while maintaining a substantial stake in the company. Despite the stock’s 62% decline over the past year, InvestingPro data shows MGPI maintains strong financial health with a ’GOOD’ rating and has consistently paid dividends for 16 consecutive years. For deeper insights into MGPI’s valuation and future prospects, access the comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, MGP Ingredients reported mixed financial results for the first quarter of 2025. The company missed earnings per share (EPS) estimates, posting $0.36 against a forecast of $0.38, but exceeded revenue expectations with $121.7 million compared to the anticipated $119.82 million. Despite these mixed results, MGP Ingredients reaffirmed its 2025 guidance, projecting net sales between $520 million and $540 million and adjusted EBITDA of $105 million to $115 million. The company also highlighted strong operational cash flow, which increased to $44.7 million, and significant declines in sales and EBITDA, with a 29% decrease in consolidated sales and a 46% drop in adjusted EBITDA. MGP Ingredients is focusing on its Premium Plus portfolio and product innovations to drive growth, with the Penelope brand exceeding expectations. Interim CEO Brendan Gahl emphasized the company’s focus on its Premium Plus portfolio as a growth engine and highlighted proactive measures to de-risk the brown goods business. Additionally, the company successfully upsized its credit facility from $400 million to $500 million, enhancing its liquidity and financial flexibility.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.